Viewing StudyNCT01515527

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 12:11 AM
Last Modification Date: 2024-10-26 @ 10:46 AM
Study NCT ID: NCT01515527
Status: RECRUITING
Last Update Posted: 2024-06-27
First Post: 2012-01-13
Brief Title: Cladribine Plus Low Dose Cytarabine LDAC Alternating With Decitabine in Patients With Acute Myeloid Leukemia AML or High-Risk Myelodysplastic Syndrome MDS
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Leukemia
Keywords:
Name View
Leukemia View
Acute myeloid leukemia View
AML View
myelodysplastic syndrome View
MDS View
Cytarabine View
Ara-C View
Cytosar View
DepoCyt View
Cytosine Arabinosine Hydrochloride View
Decitabine View
Dacogen View
Cladribine View
Leustatin View
2-CdA View